Over the past decade, Contract Research Organizations (CROs) have consumed a growing proportion of outsourced research across discovery, pre-clinical, and clinical development activities. In order to deliver efficient, high quality services, they’ve been some of the fastest adopters of digital pathology. It’s no surprise, then, as they look to take the next step in addressing dynamic challenges and deliver the next generation of differentiated solutions for their sponsors, they are also some of the most eager adopters of our solution, Concentriq® for Research. Here are the top 5 reasons that l ..read more

In the dynamic world of healthcare technology, the integration of Digital Imaging and Communications in Medicine (DICOM) into digital pathology represents a groundbreaking shift. Proscia’s commitment to DICOM is a reflection of how this standard is redefining the management and utilization of data to change the way we use images to advance our understanding and treatment of disease. The Strategic Importance of DICOM in Digital Pathology DICOM’s role in digital pathology is multifaceted and critical for several reasons: Interoperability The use of proprietary image formats takes more effort to ..read more

In the challenging and lengthy process of drug development, which typically spans 10 to 15 years and costs an estimated $2.6 billion (1), a dynamic shift is occurring in the approach taken by pharmaceutical companies: quality over quantity. AstraZeneca, for example, prioritized the quality of research and development (R&D), resulting in a notable increase in the proportion of molecules successfully progressing from the preclinical to the Phase III trial stage. The percentage has risen from 6% between 2005-10 to 19% from 2012-2016, indicating a positive shift in drug development outcomes. A ..read more

The United Kingdom (UK) National Screening Committee recently released a recommendation on the critical role of digital pathology, and, in response, the government has agreed to its broader implementation. This comes amidst a long-standing struggle to deliver high-quality, timely pathology services. By examining the UK’s technology-centric response, other nations can glean lessons crucial for right-sizing the practice of pathology and readying their healthcare systems for the future of diagnostic medicine. Background On The UK’s Pathology ChallengesThe pathology sector in the UK has been under ..read more

In the ever-evolving healthcare landscape, tech-enabled innovation has been a game changer. This field has gained significant traction in recent years, and evidence can be seen at pathology conferences around the world. At the recent European Congress of Pathology held in my home city of Dublin, it was quite evident the push and desire to streamline and enhance the efficiency of digital pathology workflows is stronger than ever. As part of that push, laboratories are increasingly turning to Laboratory Information System (LIS) integration to make their digital pathology world go around! In this ..read more

In the pharmaceutical industry, all companies, regardless of their size or area of focus, aim to optimize returns on approved therapies, streamline development processes and minimize trial failures. With the industry poised for further growth and an influx of innovative therapeutics and cell and gene therapies, selecting the most suitable Contract Research Organization (CRO) to form a partnership becomes mission critical. Outsourcing research projects to CROs is a well-established practice and market reports project a substantial growth rate of nearly 8% in R&D outsourcing until 2030(1). A ..read more

In digital pathology, where precision and accuracy are paramount, the role of automated quality control (QC) solutions is becoming increasingly vital. Automated quality control solutions identify slide and tissue artifacts so the laboratory can identify affected slides, creating efficiency benefits for the workflow and improving data quality for research and analysis.  However, the efficacy of an automated quality control solution is dependent on two crucial components: a robust development dataset and a meticulous validation and testing process. Proscia’s Automated QC solution has been t ..read more

Casey Wahl is a Senior Product Manager, Core Platform and AI at Proscia In the fast-evolving field of digital pathology, advancements in technology have transformed the way laboratory professionals analyze and interpret tissue samples. Automated quality control software solutions, such as artifact detection algorithms, play a crucial role in ensuring quality research by flagging artifacts that affect slide image quality. Laboratories can now benefit from advancements in automated quality control sensitivity settings that allow configurability for the laboratory’s unique workflow needs. Artifac ..read more

Dr. Thomas Sollie is the Medical Director at Proscia, and Histopathology Consultant, Akademiska sjukhuset, Uppsala, and Universitetssjukhuset Örebro, in Sweden.   In its century-long history, the medical sub-discipline of pathology has experienced continuous change, improvement, and advancement. Today’s challenge is digital pathology, which digitizes specimen slides and lets pathology teams use computer-based technology to view, manage, share, and analyze those slides.  Digital pathology offers proven benefits. But humans generally dislike change, no matter how beneficial. What will ..read more

Steve Jobs famously said that the most precious resource we have is time. It’s a sentiment that drives people to ponder how much time they have and how they can make the most of it. But in the pharmaceutical industry, it’s different: time is something we compete against. Pharmaceutical, biopharmaceutical, and contract research organizations (CROs) continuously race to deliver new medications and treatments that will help people survive and thrive.  So, when I talk to industry leaders, it’s no surprise that they are always looking for new ways to accelerate their preclinical discovery and ..read more